News
Director/PDMR Shareholding
07 October 2013
The Company received notification on 4 October 2013 that, Alan Reade, Non-Executive Chairman of the Company, purchased on that date 675,000 common shares of US$0.001 in the Company ("Common Shares") at a price of 5 pence per share. 227,000 of the Common Shares purchased were purchased in Alan Reade's wife's name.
Following this transaction, Alan Reade is beneficially interested in 10,486,358 Common Shares representing an interest of 6.25 per cent of the total voting rights of the Company. In addition, Alan Reade is interested in 2,645,695 stock appreciation right options over Common Shares as follows:
| Options Held | Option Exercise Price | Expiry Date |
| 1,000,000 | 6p | 25 April 2022 |
| 100,570 | 12p | 6 March 2022 |
| 550,000 | 10.5p | 4 February 2020 |
| 995,125 | 12p | 20 October 2020 |
For further information please contact:
| TyraTech Inc. Alan Reade, Non-Executive Chairman Bruno Jactel, Chief Executive Officer |
Tel: +44 7841978709 Tel: +1 919 415 4340 |
| N+1 Singer, Nominated Adviser and Joint Broker Jonny Franklin-Adams / Alex Wright |
Tel: +44 20 7496 3000 |
| First Columbus LLP, Joint Broker Chris Crawford |
Tel: +44 20 3002 2070 |
| Walbrook, Financial PR and IR Bob Huxford /Guy McDougall (Public Relations) Paul Cornelius (Investor Relations) |
Tel: +44 20 7933 8792 Tel: +44 20 7933 8794 |
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.